Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Aug 01, 2021 1:08pm
228 Views
Post# 33638460

RE:RE:RE:RE:Why the delay?

RE:RE:RE:RE:Why the delay?
Agree that the result will be confusing. I do think that the 90 day results after one treatment are still also very important.

I like the idea of making own charts. I'm bored so this is my attempt. Is this correct? Would be nice if they told us which one and when got an optimized 2nd treatment.

    90 Day notes            
ph1b 1 NR comments about the "procedure" not being optimized but optimized dose
  2 CR original success story patient        
  3 CR original success story patient        
Phase 2 - non-optimized first tx 4 NR listed as "removed" in January 2021 quarterly    
  5 NR listed as "removed" in January 2021 quarterly    
  6 NR listed as "removed" in January 2021 quarterly    
  7 NR listed as "removed" in January 2021 quarterly    
  8 NR listed as "removed" in January 2021 quarterly    
  9 NR              
  10 NR              
  11 CR              
  12 CR              
  13 CR              
  14 PR              
  15 PR              
Phase 2 optimized from day 1 16 NR might be the patient that passed away with a 30day negative cytology
  17 CR              
  18 CR              
  19 Pending              
  20 Pending              
  21 Pending              
  22 Pending              
  23 Pending              
<< Previous
Bullboard Posts
Next >>